Safety Evaluation of Iopamidol Contrast Medium Used for Radiological Examination of a Local Clinic in Korea

방사선 검사에 사용되는 조영제 Iopamidol의 안전성 평가

  • Park, Chang-Mook (College of Pharmacy, CBITRC, Chungbuk National University) ;
  • Lee, Bo-Reum (College of Pharmacy, CBITRC, Chungbuk National University) ;
  • Song, Tea-Bum (College of Pharmacy, CBITRC, Chungbuk National University) ;
  • Jang, Je-Kwan (College of Pharmacy, CBITRC, Chungbuk National University) ;
  • Lee, Yu-Jeung (College of Pharmacy, CBITRC, Chungbuk National University) ;
  • Lee, Myung-Koo (College of Pharmacy, CBITRC, Chungbuk National University) ;
  • Lim, Sung-Cil (College of Pharmacy, CBITRC, Chungbuk National University)
  • Received : 2009.04.24
  • Accepted : 2009.08.14
  • Published : 2009.12.31


Contrast media are substances that are used to enhance the contrast of structures or fluids within the body in medical imaging. Those are commonly used to enhance the visibility of blood vessels and the gastrointestinal tract. The aim of this study is to evaluate patients who got injected iopamidol, developed as one of contrast medium regarding changes in cardiovascular system and especially, adverse drug reactions. This study were performed on randomly selected a total of 51 patients (range of 15~85 years old) who got injected contrast medium, Iopamidol at a P hospital in Gyeonggi province from September 22nd, 2008 to January 24th, 2009. Data were collected by questionnaire though person to person. We analyzed the data by SPSS (Version 12. for windows). Methods of analysis were frequency and cross analysis. In results, 19.6% (n=10) were founded for adverse drug reactions of contrast medium. 25.0% (n=4) of 10 patients who had adverse drug reactions of contrast medium had took abdomen contrast test. 2 patients of those took contrast test for chest. Also, 3.9% (n=2) patients felt vomiting and nausea after injection of contrast medium. In conclusion, 19.6% patients experienced adverse drug reaction of contrast medium. Therefore, when taking radiation test, we should make efforts to minimize adverse drug reactions to achieve suitable and effective treatment.


Supported by : 교육과학기술부


  1. Kim, Y. S., Song, S. W., Ku, Y. M., Song, H. H., Yoon, S. A., Song, H. C., Kim, Y. O., Kim, K. T., Chang, Y. S. and Bang, B. K. : Clinical Characteristics and risk factors of contrast dye nephrotoxicity in patients performing arteriography. The Korean Journal of Nephrology 23, 248 (2004)
  2. William, H. B. and Dennis, P. S. : Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR 157, 1153 (1991)
  3. ESUR Contrast Media Safety Committe. : ESUR Guildlines on Contrast Media. Euroean. Society of Urogenital Radiology (2007)
  4. Kim, Y. D. : The side effect of contrast media and its related factors in contrast enhanced computed tomography. Chonnam National University (2005)
  5. Kang, Y. H. : The Precaution Duty and the Product Liability for Adverse Reaction to the contrast Media. DBPIA 30, 305 (2007)
  6. 조선행, 김문석, 강길선, 김정안, 이해방 : 생체적합성 유.무기나노 입자를 이용한 조영제의 최근 개발 동향. Polymer Science and Technology 15, 4 (2004)
  7. Choi, M. J., Kang, G. S., Yu, J. C., Paeng, D. G. and Rhim, S. M. : Magnitudes of harmonic components emitted from ultrasonic contrast agent of in response to a diagnostic ultrasound: Theoretical consideration. 한국음향학회지 24, 78 (2005)
  8. Kwon, K. S. : Anlaysis of Adverse Reactions to CT contrast Medium. University of Ulsan (2004)
  9. Lee, J. W., Kim, T. K., Kim, S. H., Kim, H. B., Kim, S. H., Hwang, S. I. and Yeon, K. M. : Efficacy of pamiray as a nonionic intravenous contrast material: Experimental study using normal rabbits. J. Korean Raiol. Soc. 42, 379 (2000)
  10. Kurt, G. H., Tony, P. S., Andrew, H. C. and Jon, H. L. : Nephrotoxicity from contrast material in renal insufficiency: Ionic versus nonionic agents. Radiology 179, 849 (1991)
  11. Patrick, R. P., Robert, G. M., Adnan, S., Deepak, V. G., Michael, C. F., Terry, O., John, W. and Fred, T. L. : Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model. JOP. J. Pancreaus. 7, 27 (2006)
  12. Lim, K. Y., Goo, J. M., Kim, S. H. and Kim, J. H. : Clinical efficacy of pamiray as a nonionic intravenous contrast material for abdominal CT. J. Korean Radiol. Soc. 49, 197 (2003)
  13. Kim, S. Y. : Preventing acute kidney injury induced by contrast medium. The Korean Journal of Nephrology 26, 657 (2007)
  14. Giancarlo, M., Emilio, A., Ivana, M., Gianfranco, L., Jeness, C., Marco, G., Monica De, M., Stefano, G., Franco, F, Piero, M., Fabrizio, V. and Antonio, L. B. : N-Acetylcystein and contrastinduced nephrpathy in primary angioplasty. N. Engl. J. Med. 354, 2773 (2006)
  15. Murphy, S. W., Barrettd, B. J. and Parfrey, P. S. : Contrast nephrophropathy. J. Am. Soc. Nephorol. 11, 177 (2000)
  16. Martin, T., Marcus Van Der Giet., Carola, S., Ulf, L., Dieter, L. and Walter, Z. : Prevention of radiographic-contrast-agentinduced reductions in renal function by acethycysteine. N. Engl. J. Med. 343, 180 (2000)
  17. Paul, R. B., Elizabeth, J., Frank, R., Michael, D. B. and Christian HR Wriedt. : A severe, late reaction to radiological contrast media mmimicking a sepis syndrome. Australasian Radiology 43, 360 (1999)
  18. Koenraad, J. O., Marie-Requal, O., Silvia, O., Pablo, R. R. and Stuart, G. S. : Universal use of nonionic iodinated contrast medium for CT: Evaluation of safety in a large Urban teaching hospital. AJR 185, 31 (2005)